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The regulation of memory CD4+ helper T (Th) cell
function, such as polarized cytokine production,
remains unclear. Here we show that memory T helper
2 (Th2) cells are divided into four subpopulations by
CD62L and CXCR3 expression. All four subpopula-
tions produced interleukin-4 (IL-4) and IL-13,
whereas only the CD62LloCXCR3lo population
produced IL-5 accompanied by increased H3-K4
methylation at the Il5 gene locus. The transcription
factor Eomesodermin (encoded by Eomes) was
highly expressed in memory Th2 cells, whereas its
expression was selectively downregulated in the
IL-5-producing cells. Il5 expression was enhanced
in Eomes-deficient cells, and Eomesodermin was
shown to interact with the transcription factor
GATA3, preventing GATA3 binding to the Il5
promoter. Memory Th2 cell-dependent airway
inflammation was attenuated in the absence of the
CD62LloCXCR3lo population but was enhanced by
Eomes-deficient memory Th2 cells. Thus, IL-5
production in memory Th2 cells is regulated by
Eomesodermin via the inhibition of GATA3 activity.
INTRODUCTION
Effector helper T (Th) cells can be categorized into at least three
subsets: T helper 1 (Th1), Th2, and Th17 cells (O’Shea and Paul,
2010; Reiner, 2007; Zhu et al., 2010). Th1 cells produce large
amounts of interferon-g (IFN-g) and direct cell-mediated
immunity against intracellular pathogens. Th2 cells produce
interleukin-4 (IL-4), IL-5, and IL-13 and are involved in humoral
immunity and allergic reactions. The recently identified subset
Th17 cells produce IL-17A, IL-17F, and IL-22 and are thought
to contribute to certain autoimmune diseases (Dong, 2008;
Korn et al., 2009).
Several transcription factors that control the differentiation
and function of these Th cell subsets have been identified.
Among them, GATA3 appears to be a critical transcription factor
for Th2 cell differentiation (Ho et al., 2009; Zheng and Flavell,I1997), T-bet for Th1 (Szabo et al., 2003), and RORgt for Th17
(Ivanov et al., 2006). GATA3 induces chromatin remodeling at
Th2 cytokine gene loci in developing Th2 cells (Ansel et al.,
2006;Wilson et al., 2009) and plays an essential role in the estab-
lishment of ‘‘Th2 cell identity:’’ that is, the ability to produce large
amounts of Th2 cytokines upon antigenic restimulation
(Nakayama and Yamashita, 2008). GATA3 is also known to act
as a transcriptional activator for Th2 cytokine genes, particularly
for IL-5 and IL-13 (Klein-Hessling et al., 2008; Siegel et al., 1995).
Th2 cell identity is maintained in memory Th2 cells for long
periods in vivo (Nakayama and Yamashita, 2008). Memory Th2
cells maintain the cardinal features of Th2 cells, such as the
selective production of Th2 cytokines, high-level expression of
Gata3, and histone modifications at the Th2 cytokine gene loci
via the expression of the nuclear factor mixed-lineage leukemia
(MLL), a mammalian homolog of the Drosophila trithorax (Yama-
shita et al., 2006). However, the precise mechanism governing
the selective production of each cytokine (IL-4, IL-13, and IL-5)
in memory Th2 cells remains unclear.
Immunological memory is a hallmark of acquired immunity
(Kalia et al., 2006; Lefranc¸ois, 2006; Stockinger et al., 2006;
Williams and Bevan, 2007). Two major subsets of memory
CD8+ T cells have been described: central memory T (Tcm) cells
and effectormemory T (Tem) cells (Kaech andWherry, 2007; Sal-
lusto et al., 2004). Tcm cells preferentially express CD62L
(L-selectin), which allows recirculation through lymph nodes.
Tem cells lack CD62L and yet express other homing receptors
needed for migration into nonlymphoid organs and upon restim-
ulation with antigen Tem cells are immediately capable of
effector cytokine production, whereas Tcm cells proliferate to
produce new effector cells, which then acquire these functions
(Seder and Ahmed, 2003). Chemokine receptors have been
instrumental in the characterization of memory T cell subsets
with distinct migratory capacity and effector functions (Wood-
land andKohlmeier, 2009). For example, the chemokine receptor
CCR7 discriminates between lymph node-homing central
memory T cells and tissue-homing effector memory T cells,
whereas expression of the B cell follicle-homing receptor
CXCR5 identifies follicular helper T cells (King, 2009). In addition,
CXCR3 is preferentially expressed on Th1 cells, whereas CCR4
is expressed on Th2 cells (Song et al., 2005). The ligands for
these receptors are inflammatory chemokines and chemoattrac-
tants, which are expressed in inflammatory tissues and mediate
the selective recruitment of different types of effector cellsmmunity 35, 733–745, November 23, 2011 ª2011 Elsevier Inc. 733
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in cytokine production potential is suggested in memory CD4+
T cells (MacLeod et al., 2009; McKinstry et al., 2010; Pepper
et al., 2010; Sallusto and Lanzavecchia, 2009; van Leeuwen
et al., 2009). However, the functional distinctions amongmemory
CD4+ T cell subpopulations are poorly understood. A greater
understanding of functional memory T cell subpopulations and
their regulation of cytokine production may lead to the design
of better vaccine and immune-targeted therapies (Seder et al.,
2008).
In this study, we show that IL-5-producing memory CD4+
T cells exist selectively in the CD62LloCXCR3lo subpopulation
and have investigated the molecular mechanism underlying the
regulation of IL-5 expression in these cells. IL-5 production in
memory Th2 cells was uniquely regulated by the expression of
Eomesodermin (Eomes) and was associated with histone H3-
K4methylationmarks at the Il5 promoter (Il5p). Eomes interacted
with GATA3 and prevented GATA3 binding to the Il5p. Further-
more, Eomes-deficient memory Th2 cells showed increased
production of IL-5 and induced enhanced allergic airway inflam-
mation, indicating a role for Eomes inmemory Th2 cell responses
in vivo.
RESULTS
IL-5 Is Selectively Produced by the CD62LloCXCR3lo
Subpopulation of Memory Th2 Cells
Antigen-specific functional memory Th1 and Th2 cells are effi-
ciently generated in vivo by adoptive transfer of effector Th1 or
Th2 cells (Figure S1A available online; Nakayama and Yama-
shita, 2009). To identify functionally distinct subpopulations of
memory Th1 and Th2 cells, we examined the expression of cell
surface marker antigens, including CXCR3, IL-2Rb, DX5,
CD69, IL-7Ra, IL-4Ra, PD1, CD61, CCR4, and CD62L on
memory Th2 cells. Memory Th2 cells were divided into at least
four distinct subpopulations according to their expression of
CXCR3 and CD62L, IL-2Rb and CD62L, or DX5 and CD62L
(Figures 1A and S1B). Effector Th2 cells showed a CD62Llo
CXCR3lo phenotype (Figure S1C). Interestingly, a substantial
proportion of in-vivo-generated memory Th2 cells expressed
CXCR3, a well-knownmarker for Th1 cells. The transfer of sorted
CXCR3lo effector Th2 cells also generated four subpopulations
(CD62LloCXCR3lo, CD62LloCXCR3hi, CD62LhiCXCR3lo, and
CD62LhiCXCR3hi) of memory Th2 cells, the same as that
observed for unsorted Th2 cells (Figure S1D). We assessed
expression of Th1 and Th2 cytokines in these four subpopula-
tions after anti-TCR stimulation (Figures 1B, 1C, S1E, and
S1F). As shown in Figures 1B and 1C, all four subpopulations ex-
pressed a large amount of IL-4 and IL-13, whereas only the
CD62LloCXCR3lo subpopulation expressed IL-5. The production
of IFN-g bymemory Th2 cells tended to be higher in the CXCR3hi
population, although the amount was still very low relative to Th1
cells. Selective expression of Il5 was also detected in the
CD62LloIL-2Rblo subpopulation (Figure S1E), but no difference
was observed for Il5 expression between the DX5 high or low
populations (Figure S1F). Memory Th1 cells were also subdi-
vided into at least four subpopulations according to their expres-
sion of CD62L andCXCR3 (Figure S1G). However, no expression
of Th2 cytokines (IL-4, IL-5, or IL-13) was observed and the734 Immunity 35, 733–745, November 23, 2011 ª2011 Elsevier Inc.expression of IFN-g in memory Th1 cells was higher in the
CXCR3hi subpopulation (Figures S1H and S1I). The proportion
of CD62Lhi memory Th2 cells was increased in the lymph nodes
and decreased in the lung and liver as compared to spleen
(Figure S1J).
Covalent histone modifications, such as histone H3-K4 meth-
ylation and histone H3-K9 acetylation, are typically associated
with transcriptionally active chromatin. Particularly, histone
H3-K4 methylation is a marker for the maintenance of the
permissive conformation of chromatin (Ruthenburg et al.,
2007). The degree of histone H3-K4 methylation at the Il5p was
selectively higher in the CD62LloCXCR3lo population as
compared to the other three subpopulations, and the degree
was equivalent to effector Th2 cells (Figure 1D). As a control,
a total histone H3 ChIP assay was performed and equivalent
levels of histone were detected (Figure S1L). Similar patterns
of H3-K4 methylation were observed at other regions around
the Il5 gene locus (Il5 exon3 and Il5 U1) (Figures S1K and
S1M). These results indicate that the CD62LloCXCR3lo subpop-
ulation of memory Th2 cells selectively produces IL-5 accompa-
nied by histone H3-K4 methylation marks at the Il5p.
Naturally existing CD44hi memory phenotype CD4+ (MPCD4)
T cells are considered to be nearly indistinguishable from
memory cells generated in response to defined antigen (Boyman
et al., 2009). We found that spleen MPCD4+ T cells could also be
divided into four distinct subpopulations according to their
expression of CXCR3 and CD62L, although the proportion of
CD62LhiCXCR3hi population was relatively small as compared
to memory Th2 cells generated by effector Th2 cell transfer
(Figures 1E and S1N). Upon restimulation, selective Il5 mRNA
and IL-5 protein expression by the CD62LloCXCR3lo population
ofMPCD4+ T cells was detected (Figures 1F and 1G). Expression
of IL-4, IL-13, and IFN-g was observed in the CD62Llo subpopu-
lation, as reported previously (Sallusto et al., 2004). Furthermore,
in the CD62LloCXCR3lo population of MPCD4+ T cells, the
degree of H3-K4 methylation was highest at the Il5p after
anti-TCR stimulation (Figure 1H). These results indicate that
IL-5-producing cells were detected selectively in the
CD62LloCXCR3lo population of MPCD4+ T cells.
Decreased Expression of Eomes, but Not Tbx21,
Enhanced IL-5 Production by Memory Th2 Cells
Wenext analyzed theexpressionof genespreviously shown tobe
involved in the regulation of Il5 transcription (Gata3, Cebpa, Maf,
Nfat1, Nfat2, Rela, Jun, Junb, Jund, and Fra2) in the four subpop-
ulations (CD62LloCXCR3lo, CD62LloCXCR3hi, CD62LhiCXCR3lo,
and CD62LhiCXCR3hi) of memory Th2 cells, but none of these
genes were specifically expressed in the CD62LloCXCR3lo pop-
ulation (data not shown). Intracellular cytokine staining of IL-4,
IL-5, and IL-13 showed that only a fraction of the
CD62LloCXCR3lo Th2 memory cells produced IL-5 (about
10%), although the IL-5-producing cells existed selectively in
this population (Figure S2A). In contrast, IL-4- and IL-13-
producing cells were almost equivalent (around 20%–25%)
among these four subpopulations. To identify genes that may
control the expression of Il5 in memory Th2 cells, a DNA micro-
array analysis was performed on IL-5+ and IL-5 memory Th2
cells purified with an IL-5 secretion assay kit (Figure S2B). The
purified IL-5+ memory Th2 cells showed decreased levels of
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Figure 1. IL-5 Production Is Selectively Detected in
the CD62LloCXCR3lo Subpopulation of Memory
Th2 Cells
(A)Fiveweeksafter transferofDO11.10TCRTgTh2cells into
BALB/c nu/nu mice, donor-derived KJ1+ memory Th2 cells
in the spleen were stained with CD62L and CXCR3 mAbs.
Four subpopulations (CD62LloCXCR3lo, CD62LloCXCR3hi,
CD62LhiCXCR3lo, and CD62LhiCXCR3hi) of memory Th2
cells were sorted by fluorescence activated cell sorting
(FACS).
(B) Quantitative RT-PCR analysis of Il4, Il5, Il13, and Ifng in
the four subpopulations of memory Th2 cells after 4 hr
stimulation with immobilized anti-TCRb.
(C) ELISA analysis of IL-4, IL-5, IL-13, and IFN-g secreted
by the four subpopulations of memory Th2 cells after 24 hr
stimulation with immobilized anti-TCRb.
(D) A ChIP assay was performed with anti-trimethylhistone
H3-K4 at the Th2 cytokines gene loci and Hprt promoter
(Hprtp) from naive CD4+ T, effector Th2, and the four
subpopulations of memory Th2 cells after 4 hr stimulation
with immobilized anti-TCRb. The degree of this modifi-
cation was determined by quantitative RT-PCR.
Five independent experiments (B) and three independent
experiments (C and D) were performed with similar results.
(E) CD44hi memory phenotype CD4+ (MPCD4+) T cells
from the spleen were stained with CD62L and CXCR3
mAbs. Four subpopulations were sorted by FACS.
(F–H) Quantitative RT-PCR (F), ELISA (G), and ChIP assay
(H) were performed as described in (B)–(D). Three inde-
pendent experiments were performed with similar results.
The mean values with standard deviations (SD) are shown
(B–D, F–H).
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Eomesodermin Suppresses IL-5 in Memory Th2 CellsCD62L and CXCR3 (Figure S2C). A summary of the differentially
expressed genes is shown in Table S1.We focused especially on
nuclear factors and confirmed their expression via quantitative
RT-PCR. mRNA levels of Eomes and Tbx21 were significantly
lower, and those of Rora and Pparg were significantly higher in
IL-5+ memory Th2 cells as compared to IL-5memory Th2 cells
(Figures 2A and S2D). Other nuclear factors listed in Table S1
were either not detected substantially or not expressed differen-Immunity 35, 733–tially between IL-5+ and IL-5memory Th2 cells
when measured by RT-PCR (data not shown).
Among the four subpopulations of memory
Th2 cells, no significant difference was
observed in the expression of Eomes or Tbx21,
although the expression of these two genes
tends to be higher in the CD62LloCXCR3hi pop-
ulation (Figure S2E). The expression of Rora and
Pparg were highest in the CD62LloCXCR3lo
subpopulation.
We next analyzed expression of Eomes,
Tbx21, Rora, and Pparg mRNA (Figures 2B
and S2F) and Eomes and T-bet protein (Fig-
ure 2C) in naive CD4+ T cells, stimulated effector
Th1 and Th2 cells, memory Th1 and Th2 cells,
and activated CD8+ T cells. The expression of
Eomes in memory Th2 cells was almost equiva-
lent to stimulated effector Th1 cells and was
slightly lower than activated CD8+ T cells. In
contrast, the expression of Tbx21 in memoryTh2 cells was considerably lower than that of effector or memory
Th1 cells. Moreover, intracellular staining of Eomes revealed that
the majority of memory Th2 cells expressed substantial amounts
of Eomes protein (Figure 2D). Again, marginal expression was
detected in effector Th2 cells. In addition, both MPCD4+
T cells and MPCD8+ T cells expressed substantial amounts of
Eomes protein as compared to naive CD4+ T cells, although
the expression was lower in MPCD4+ T cells (Figure S2G). These745, November 23, 2011 ª2011 Elsevier Inc. 735
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Figure 2. Decreased Expression of Eomes, but Not Tbx21, Enhanced IL-5 Production by Memory Th2 Cells
(A and B) Quantitative RT-PCR analysis of Eomes and Tbx21 in IL-5+ and IL-5 effector ormemory Th2 cells (A) and naive CD4+ T, stimulated effector Th1 and Th2,
memory Th1 and Th2, and activated CD8+ T cells (B).
(C) Protein expression of Eomes and T-bet in stimulated effector Th1 and Th2, memory Th1 and Th2, and activated CD8+ T cells. Band intensities were measured
with a densitometer and arbitrary densitometric units are shown.
(D) Intracellular staining profiles of Eomes in stimulated effector, memory Th2, and activated CD8+ T cells are shown. Gray filled histogram shows isotype control
staining.
(E) Quantitative RT-PCR analysis of Eomes and Tbx21 in IL-5+ and IL-5 MPCD4+ T cells.
(F) Effect of siRNA gene targeting of Eomes and Tbx21 on Il5 expression in memory Th2 cells. Memory Th2 cells were introduced with control (Cont. KD), Eomes
(Eomes KD), or Tbx21 siRNA (Tbx21 KD) and cultured with medium for 24 hr. Representative expression of Eomes and Tbx21 in Eomes and Tbx21 siRNA gene-
targeted memory Th2 cells (top). The number in the histogram represents mean fluorescent units. Gray filled histogram shows isotype control staining. Quan-
titative RT-PCR analysis of indicated molecules in these cells after 6 hr stimulation with immobilized anti-TCRb are shown (bottom).
(G) siRNA gene targeting analysis in MPCD4+ T cells.
Themean valueswith standard deviations (SD) are shown (A, B, E–G). At least three independent experiments (A–G) were performedwith similar results. *p < 0.05.
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Eomesodermin Suppresses IL-5 in Memory Th2 Cellsresults indicate that the expression of Eomes was increased in
memory Th2 cells and that mRNA expression of Eomes was
very low in IL-5+ memory Th2 cells. Similar results were obtained
from assessment of the expression of these genes in IL-5+ and
IL-5 MPCD4+ T cells (Figure 2E). Therefore, downregulation of
Eomes may be required for IL-5 production in memory Th2 and
MPCD4+ T cells.
To assess the role of Eomes and Tbx21 in Il5 expression in
memory Th2 cells, a transient siRNA gene targeting system
was established. Eomes or Tbx21 siRNA gene targeting in
memory Th2 cells resulted in decreased Eomes and Tbx21
mRNA and protein expression of Eomes and T-bet, respectively
(Figure 2F, top). As shown in Figure 2F (bottom), siRNA gene tar-
geting of Eomes induced increased expression of Il5 but no
substantial effect was observed in the expression of Il4 and
Il13. In contrast, decreased expression of Tbx21 by siRNA
gene targeting did not affect Il5 expression in memory Th2 cells.
Similar results were obtained in the experiments with MPCD4+
T cells (Figure 2G). Eomes siRNA gene targeting induced
a decreased expression of Il2rb in memory Th2 cells (Figure 2F;
Intlekofer et al., 2005). Again, no effect was observed after Tbx21
siRNA gene targeting, although the expression levels of Tbx21
were decreased substantially. The expression ofRora and Pparg
was increased in IL-5+ memory Th2 cells (Table S1 and Fig-
ure S2D), but siRNA gene targeting of these genes had no effect
on the expression of Il5 (Figure S2H). These results indicate that
Eomes but not T-bet plays an important role in the regulation of
Il5 expression in memory Th2 and MPCD4+ T cells.
Eomes Limits the Production of IL-5 in
the CD62LloCXCR3lo Population of Memory Th2 Cells
Next, we performed Eomes siRNA experiments on each of the
four subpopulations (CD62LloCXCR3lo, CD62LloCXCR3hi, CD62Lhi
CXCR3lo, and CD62LhiCXCR3hi) of memory Th2 cells. More than
a 2-fold increase in the expression of Il5 was detected in the
CD62LloCXCR3lo subpopulation (Figure 3A), whereas no obvious
increase in Il5 expression was detected in the other three
subpopulations. Next, the degree of H3-K4 methylation at the
Il5p was assessed in the four subpopulations in addition to the
CD62LloCXCR3lo population depleted of IL-5+ cells. Histone
H3-K4methylation at the Il5p region in theCD62LloCXCR3lo pop-
ulation depleted of IL-5+ cells was almost equivalent to that of the
whole CD62LloCXCR3lo population (Figure 3B). The other three
subpopulations showed a low level of histone H3-K4methylation
similar to that observed in effector Th1 cells. We confirmed
reduced Il5mRNAexpression in theCD62LloCXCR3lo population
depleted of IL-5+ cells (Figure 3C). These results indicate that
the level of histone H3-K4 methylation at the Il5p region in the
CD62LloCXCR3lo population is high even in the absence of
IL-5-producing cells. Therefore, Eomes appears to limit the tran-
scriptionof Il5but doesnot control the histoneH3-K4methylation
in the CD62LloCXCR3lo population (Figure S3, top and middle).
Eomes-dependent and -independent mechanisms may operate
in the other three subpopulations (Figure S3, bottom).
Eomes Negatively Regulates the Production of IL-5
in Memory Th2 Cells
GATA3 is known to bind the Il5pdirectly and controls its promoter
activity in Th2 cells (Klein-Hessling et al., 2008). First, intracellularIstaining of IL-4, IL-5, GATA3, and Eomes was performed on the
four subpopulations after anti-TCR restimulation. Most of the
IL-5-producing cells expressed high amounts of GATA3 protein
in both the whole (Figure 4A, far left) and the CD62LloCXCR3lo
population of memory Th2 cells (Figure 4A, GATA3 versus IL-5
profile). Conversely, the majority of IL-5-producing memory Th2
cells expressed lower levels of Eomes protein (Figure 4A, Eomes
versus IL-5 profile). In contrast, IL-4-producing cells were de-
tected in both Eomeshi and Eomeslo or GATA3hi and GATA3lo
populations (Figure 4A, GATA3 versus IL-4 and Eomes versus
IL-4 profiles).WedetectedGATA3andEomesdouble expressing
cells in all four subpopulations (approximately 20% to 30%)
but also a reciprocal expression profile of GATA3 and Eomes
was noted in the four subpopulations of memory Th2 cells
(Figure 4A, GATA3 versus Eomes profiles). Eomes siRNA gene
targeting resulted in an increase in the percentage of IL-5-
producing cells in the Eomeslo population (0.6% versus 2.1%)
and decreased proportion of GATA3hiEomeshi cells (20.9%
versus 10.2%) with increased GATA3hiEomeslo cells (28.2%
versus 38.9%) (Figure 4B). We also examined IL-5, Eomes, and
GATA3 staining in the CD62LloCXCR3lo population, and IL-5-
producing cells were predominantly detected in the GATA3hi
Eomeslo populations (Figure 4C). Eomes siRNA gene targeting
resulted in an increase in the percentage of IL-5-producing cells
in the GATA3hiEomeslo population (Figure S4). Furthermore, en-
forced expression of Eomes in effector Th2 cells suppressed
the production of IL-5 but not IL-4 or IL-13 (Figures 4D and 4E).
These results indicate that Eomes negatively regulates the
production of IL-5 inmemory Th2 cells and also effector Th2 cells
if Eomes is expressed.
Eomes Suppresses the Transcriptional Activity of
GATA3 via Inhibition of GATA3 Binding to the Il5
Promoter
To identify the molecular mechanism by which Eomes downre-
gulates the expression of Il5 in memory Th2 cells, we sought to
demonstrate the possible physical association of Eomes with
GATA3. Eomes protein associated with GATA3 was easily
detected in the precipitates even in the presence of ethidium
bromide (Figure 5A, lanes 4 and 8). Having shown that Eomes
and GATA3 can associate, several Myc-tagged Eomes mutants
were generated to determine which domains of Eomes are
important for its association with GATA3 (Figure 5B, top). The
association between the dC mutant (C-terminal region including
transactivation domain deleted; Figure 5A, lane 8) with GATA3
was equivalent to the wild-type (WT) Eomes (Figure 5A, compare
lanes 6 and 8), but the association of dT mutant (T-box region
deleted; Figure 5A, lane 7) with GATA3was very weak (Figure 5B,
middle). The amount of each protein was estimated by immuno-
blotting with anti-Myc or anti-Flag (Figure 5B, bottom). The asso-
ciation of Eomes with GATA3 was detected in memory Th2 cells
(Figure 5C). These results indicate that Eomes associates with
GATA3 in memory Th2 cells and that the T-box region is critical
for this association.
Next, to assess the effect of Eomes on the DNA-binding
activity of GATA3, a pull-down assay was performed as
described in the Experimental Procedures. The binding of
GATA3 to the consensus GATA sequence was substantially
decreased in the presence of Eomes (Figure 5D, top). Themmunity 35, 733–745, November 23, 2011 ª2011 Elsevier Inc. 737
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Figure 3. Eomes Limits the Production of IL-5 in the CD62LloCXCR3lo Population of Memory Th2 Cells
(A) Memory cells were introduced with siRNA and cytokine expression was detected by quantitative RT-PCR as described in Figure 2F.
(B) A ChIP assay was performed with anti-trimethylhistone H3-K4 Ab at the Th2 cytokine gene loci and Hprtp from effector Th1, effector Th2 cells, the four
subpopulations (CD62LloCXCR3lo, CD62LloCXCR3hi, CD62LhiCXCR3lo, andCD62LhiCXCR3hi) of memory Th2 cells and the CD62LloCXCR3lo population depleted
of IL-5+ memory Th2 cells.
(C) Quantitative RT-PCR analysis of Il5 in the four subpopulations of memory Th2 cells and the CD62LloCXCR3lo population depleted of IL-5+ memory Th2 cells.
The mean values with standard deviations (SD) are shown. Three independent experiments were performed with similar results. *p < 0.05.
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protein were also assessed (Figure 5D, middle and bottom).
We also performed a pull-down assay with the Il5p sequence
in the presence of Eomes WT or dT mutant. The binding of
GATA3 to the Il5p was substantially decreased in the presence
of Eomes WT. This suppressive effect was not observed by the
Eomes dT mutant (Figure 5E, top). The binding of Eomes to the
Il5p was not detected (Figure 5E, second panel). The quantity
of input Flag-tagged GATA3 and Myc-tagged Eomes protein
was also assessed (Figure 5E, bottom). Next, the suppressive
effect of Eomes on Il5p activity was assessed, and as expected
both WT and dC mutants efficiently suppressed Il5 activity
whereas the Eomes dT mutant did not (Figure 5F). To test the
effects of Eomes on GATA3 binding to the Il5p in Th2 cells, we
performed a ChIP assay with Eomes-overexpressing effector
Th2 cells and Eomes siRNA gene-targeted memory Th2 cells
(Figures 5G and 5H). The binding of GATA3 to the Il5p was738 Immunity 35, 733–745, November 23, 2011 ª2011 Elsevier Inc.reduced by enforced overexpression of Eomes in effector Th2
cells and was enhanced by the reduction of Eomes expression
in memory Th2 cells. These results indicate that Eomes
suppresses the transcriptional activity of GATA3 via inhibition
of GATA3 DNA binding to the Il5p in memory Th2 cells.
Memory Th2 Cell-Dependent Airway Inflammation Is
Ameliorated after CD62LloCXCR3lo Cell Depletion
Finally, we assessed the function of IL-5-producing memory Th2
cells in the CD62LloCXCR3lo subpopulation with a memory
Th2 cell-dependent allergic airway inflammation model (Yama-
shita et al., 2006). OVA-specific memory Th2 cells were first
generated in vivo (Nakayama and Yamashita, 2009), and whole
memory Th2 cells or memory Th2 cells depleted of the
CD62LloCXCR3lo population (D L/L) were transferred into
BALB/c or BALB/c nu/nu mice, and then these mice were then
challenged twice by inhalation with OVA. A no cell transfer group
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Figure 4. Eomes Negatively Regulates the Produc-
tion of IL-5 in Memory Th2 Cells
(A) Whole memory Th2 and the four subpopulations
(CD62LloCXCR3lo, CD62LloCXCR3hi, CD62LhiCXCR3lo,
and CD62LhiCXCR3hi) of memory Th2 cells were stimu-
lated in vitro with immobilized anti-TCRb for 6 hr, and
intracellular staining profiles of Eomes, GATA3, IL-5, and
IL-4 are shown with the percentage of cells in each area.
The numbers in parentheses represent standard devia-
tions.
(B) Control or Eomes siRNA gene-targeted memory Th2
cells were generated as described in Figure 2F and these
cells were stimulated in vitro with immobilized anti-TCRb
for 6 hr; intracellular staining profiles of Eomes versus IL-5,
and GATA3 versus Eomes are shown with the percentage
of cells in each area.
(C) Intracellular staining profiles of IL-5 in EomeshiGATA3hi
and EomesloGATA3hi cells in the CD62LloCXCR3lo pop-
ulation are shown.
(D and E) Naive CD4+ T cells were stimulated under Th2
cell culture conditions for 2 days, and then the cells were
infected with an Eomes-IRES-hNGFR-containing retro-
virus. Three days after infection, IFN-g versus IL-4 and
IFN-g versus IL-5 staining profiles of Eomes-infected cells
(hNGFR+) were determined by intracellular staining (D).
The hNGFR-positive infected cells were enriched by
magnetic cell sorting. Quantitative RT-PCR analysis of the
relative expression of each cytokine in infected cells was
performed 4 hr after stimulation with immobilized anti-
TCRb (E).
The mean values with standard deviations (SD) are shown.
*p < 0.05. Three (A and B) and two (C–E) independent
experiments were performed with similar results.
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Eomesodermin Suppresses IL-5 in Memory Th2 Cellswas included as a negative control (Control). A dramatic
decrease in the number of inflammatory cells, including eosino-
phils in the bronchoalveolar lavage (BAL) fluid, was observed in
the D L/L group as compared to the undepleted group (Fig-
ure 6A). A similar reduction was observed after histological anal-
ysis of the lung (Figure S5A). The concentration of IL-5 in the BAL
fluid was decreased in the D L/L group in comparison to the un-
depleted group, whereas the concentration of IL-4, IL-13, and
IFN-g was almost equivalent between the two (Figure 6B). Peri-
odic acid-Schiff (PAS) staining and the measurement of Gob5
and Muc5ac mRNA expression in the lung tissue indicatedImmunity 35, 733–decreased production of mucus in the D L/L
group (Figures 6C and 6D). Furthermore, meth-
acholine-induced airway hyperresponsiveness
(AHR) was significantly decreased in the D L/L
group (Figure 6E). In order to specifically
address the role of IL-5+ memory Th2 cells, IL-
5+ cell-depleted memory Th2 cells (IL-5) were
transferred. As expected, the infiltration of
eosinophils was decreased in the IL-5 group
as compared to the whole group (Figure 6F).
The concentration of IL-5 in the BAL fluid
was decreased in the IL-5 group whereas
the concentration of IL-4, IL-13, and IFN-g
was almost equivalent (Figure 6G). These
results indicate that allergic airway inflamma-
tion was attenuated after depletion of theCD62LloCXCR3lo population or the IL-5-producing population
of memory Th2 cells.
To assess a role for Eomes in allergic airway inflammation
and IL-5 production in vivo more directly, we generated
memory Th2 cells from Eomes-deficient (Eomes/) effector
Th2 cells. IL-5 production by Eomes/ effector Th2 cells was
equivalent to that detected in Eomes+/+ cells (Figure S5B).
Eomes/ memory Th2 cells showed reduced surface expres-
sion of CXCR3 as compared to control (Eomes+/+) (Figure 6H).
As expected, IL-5 production was dramatically increased in
Eomes/ memory Th2 cells as compared to control (Figure 6I).745, November 23, 2011 ª2011 Elsevier Inc. 739
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Figure 5. Eomes Suppresses the Transcriptional Activity of GATA3 via the Inhibition of Binding to the Il5 Promoter
(A) 293T cells were transfected with Myc-tagged Eomes or Flag-tagged GATA3, and immunoprecipitation assay was performed with anti-Flag in the absence or
presence of ethidium bromide. Immunoblotting of whole cell lysates (WCL) is also shown as a control (input).
(B) Schematic representation of Myc-tagged Eomes mutants; wild-type Eomes (WT), dC mutant with deletion of the transactivation domain (TA), and dT mutant
with deletion of T-box region (top). 293T cells were transfected with Myc-tagged WT or mutant Eomes and Flag-tagged GATA3. A coimmunoprecipitation
analysis was performed.
(C) The association of Eomes with GATA3 detected in memory Th2 cells. Coimmunoprecipitation assay with anti-GATA3 was performed with memory Th2 cells
(1 3 108 cells) after stimulation with anti-TCRb for 6 hr.
(D and E) A pull-down assay was performed as described in Experimental Procedures. Immunoblotting of total cell lysates is also shown (Input).
(F) Eomes interacted with GATA3 and suppressed GATA3-induced transcriptional activation of the Il5p. Reporter assays with the Il5p were performed with the
D10G4.1 Th2 cell line. Themean values with standard deviations of relative luciferase activity of three different experiments are shown. Stimulation was done with
PMA (30 ng/ml) plus dbcAMP (100 mM).
(G andH) A ChIP assaywas performedwith anti-GATA3 at the Il5p andHprtp in Eomes-overexpressing effector Th2 cells shown in Figure 4C (G), andmemory Th2
cells with control (Cont. KD) or Eomes siRNA (Eomes KD) shown in Figure 2F (H).
Three independent experiments were performed with similar results.
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mation by using Eomes/ memory Th2 cells. The infiltration
of inflammatory cells, mainly eosinophils, was significantly
increased in the group transferred with Eomes/ memory
Th2 cells as compared to the Eomes+/+ group (Figure 6J).
Consistent with the increased eosinophilic infiltration, the740 Immunity 35, 733–745, November 23, 2011 ª2011 Elsevier Inc.concentration of IL-5 in the BAL fluid was increased in the
Eomes/ group, whereas the concentration of IL-4 and IL-13
was almost equivalent between the two groups (Figure 6K).
Decreased levels of IFN-g in the BAL fluid of Eomes/memory
Th2 cell transferred mice were also observed. These in vivo
results indicate that memory Th2 cell-dependent allergic airway
Immunity
Eomesodermin Suppresses IL-5 in Memory Th2 Cellsinflammation was exacerbated by downregulation of Eomes in
memory Th2 cells.
DISCUSSION
We have identified functionally relevant IL-5-producing memory
Th2 cells in the CD62LloCXCR3lo subpopulation, which are
required for the induction of Th2 cell-dependent eosinophilic
airway inflammation. The possible molecular mechanisms that
control IL-5 production in memory Th2 cells are depicted in the
graphical abstract. Upon TCR stimulation, all four
CD62LloCXCR3lo, CD62LloCXCR3hi, CD62LhiCXCR3lo, and
CD62LhiCXCR3hi subpopulations can produce a large amount
of both IL-4 and IL-13. However, only a fraction of the
CD62LloCXCR3lo subpopulation can produce IL-5. In this popu-
lation, the expression of Eomes is limited, and high H3-K4 meth-
ylation at the Il5p was detected. The IL-5 nonproducing
CD62LloCXCR3lo subpopulation also shows high H3-K4 methyl-
ation at the Il5p, but this subpopulation contains two types of
cells: one expresses high amounts of both Eomes and GATA3,
and the other expresses high amounts of Eomes but low
amounts of GATA3. The other three subpopulations do not
produce IL-5 and show low H3-K4 methylation at the Il5p. These
three populations contain roughly the same proportion of
GATA3hiEomeslo, GATA3hiEomeshi, and GATA3loEomeshi cells
as compared to the CD62LloCXCR3lo population, indicating
that Eomes may not play an important role in the expression of
IL-5 in these populations. Moreover, GATA3 expression itself
appears insufficient for the expression of IL-5 in the majority of
the memory Th2 cells because very few GATA3hi cells express
IL-5 even in the absence of high-level Eomes expression. There-
fore, other unknown factors appear to repress the expression of
IL-5 or prevent the activation of IL-5 transcription in these popu-
lations, regardless of the expression of GATA3. Although the
mechanisms that regulate histone modification at the Il5 locus
in memory Th2 cells remain unknown, H3-K4 methylation
appears to be associated with the ability to produce IL-5.
The regulatory mechanism governing expression of Eomes in
CD4+ T cells has not been well established. Although previous
reports suggest that IFN-g upregulates the expression of Eomes
in CD4+ T cells (Suto et al., 2006), under some conditions, IL-4
appears to induce the expression of Eomes in antigen-stimu-
lated CD8+ and CD4+ T cells (Takemoto et al., 2006; Weinreich
et al., 2009). Based on these findings and the results of a DNA
microarray analysis via IL-5 and IL-5+ memory Th2 cells, we
have defined several candidate molecules that may participate
in control of Eomes expression in the IL-5-producing
CD62LloCXCR3lo subpopulation. Reduced mRNA expression
of the IFN-g receptor component Ifngr2, the IFN-g downstream
signaling molecule Stat1, and also the IL-4 receptor a chain
(Il4ra) were detected in IL-5+ memory Th2 cells as compared to
IL-5 memory Th2 cells, and therefore, reduced expression of
these molecules may contribute to the low expression of Eomes
in IL-5+ memory Th2 cells. A recent report showed that Eomes
can be upregulated when GATA3 expression ceases in Th2 cells
(Yagi et al., 2010). We observed a reciprocal expression profile of
GATA3 and Eomes in all four subpopulations (CD62LloCXCR3lo,
CD62LloCXCR3hi, CD62LhiCXCR3lo, and CD62LhiCXCR3hi) of
memory Th2 cells. Therefore, the counterregulation of expres-Ision of GATA3 and Eomes may exist in CD4+ T cells. Eomes-
mediated IL-5 suppression probably occurs predominantly in
GATA3 and Eomes double-expressing cells in the
CD62LloCXCR3lo population. However, it is also possible that
other Eomes-dependent and -independent mechanisms oper-
ate in this population. Eomes may mediate indirect control of
Il5 expression by altering expression and/or function of other
transcription factors or work in concert with other factors to
ultimately suppress IL-5 production. The expression of Eomes
was downregulated in memory Th2 cells after secondary chal-
lenge with antigen for 6 days (data not shown). In addition, the
upregulation of Eomes was detected also in memory CD4+
T cells induced by the immunization of antigen in vivo (data
not shown).
Eomes siRNA gene targeting experiments revealed that the
expression of Il5 is more dependent on Eomes expression as
compared to Il4 and Il13 in both memory Th2 and MPCD4+
T cells. Furthermore, enforced expression of Eomes sup-
pressed the expression of IL-5 but not IL-4 and IL-13 in
in vitro developing effector Th2 cells. Both GATA3hi and
GATA3lo memory Th2 cells produced substantial amounts of
IL-4, but only GATA3hi cells produced IL-5. Indeed, IL-5
expression is known to be more dependent on the expression
levels of GATA3 as compared to IL-4 (Inami et al., 2004).
Eomes was found to interact with GATA3 in memory Th2 cells
and suppress GATA3 DNA binding to the Il5p. These results
may explain the preferential effect of Eomes on Il5 expression
as compared to Il4 and Il13.
The current study indicates that the IL-5-producing
CD62LloCXCR3lo population of memory Th2 cells is essential
for the induction of allergic eosinophilic inflammation and
AHR and that Eomes plays an important role in suppression
of IL-5 and the induction of eosinophilic inflammation. Better
defining the IL-5-producing CD4+ T cells in allergic disorders
may help to identify appropriate targets for intervention and
the analysis of downstream target molecules of Eomes may
be of interest. The DNA microarray analysis identified several
potentially functional cell surface molecules upregulated on
IL-5+ memory Th2 cells. Interestingly, Il1rl1 (ST2) is upregulated
in IL-5+ memory Th2 cells. IL-1RL1 is also the receptor for
IL-33, a member of the IL-1 family, and IL-33- and ST2-medi-
ated signaling triggers the activation of NF-kB leading to the
production of Th2 cytokines (Kurowska-Stolarska et al., 2008;
Schmitz et al., 2005). Therefore, the IL-5-producing
CD62LloCXCR3lo population of memory Th2 cells identified in
this study could be critical in the pathogenesis of chronic
type 2 inflammation. Although preliminary, human IL-5-
producing CD45RO+ memory CD4+ T cells in the peripheral
blood showed decreased EOMES expression as compared to
IL-5 nonproducing memory CD4+ T cells, and siRNA gene tar-
geting of EOMES enhanced IL5 expression in the CD45RO+
memory CD4+ T cells (data not shown). Thus, further detailed
studies focused on the IL-5-producing memory Th2 cells in
chronic asthma models may lead to the discovery of novel ther-
apeutic targets for the treatment of asthma.
In summary, we have identified IL-5-producing functionally
relevant memory Th2 cells in the CD62LloCXCR3lo subpopula-
tion. Il5 expression is uniquely regulated by the expression of
Eomes in memory Th2 cells. Eomes plays an important role inmmunity 35, 733–745, November 23, 2011 ª2011 Elsevier Inc. 741
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Figure 6. Memory Th2 Cell-Dependent Airway Inflammation Is Ameliorated after Depletion of the CD62LloCXCR3lo Population
(A–E) OVA-specific memory Th2 cells were sorted into KJ1+ whole memory Th2 cells (whole) and memory Th2 cells depleted of the CD62LloCXCR3lo population
(DL/L) by FACS. These cells were intravenously transferred into BALB/c (A–D) or BALB/c nu/nu (E) mice. No cell transfer was performed in the control group
(Control). Airway inflammation was induced with OVA challenge.
(A) The absolute cell numbers of eosinophils (Eos.), neutrophils (Neu.), lymphocytes (Lym.), and macrophages (Mac.) in the BAL fluid are shown. The results were
calculated with the percentages of the different cell types, the total cell number per milliliter, and the volume of the BAL fluid recovered. Samples were collected
2 days after the last OVA challenge. The mean values (five mice per group) are shown with SD.
(B) ELISA analysis of IL-4, IL-5, IL-13, and IFN-g in the BAL fluid. Samples were collected 12 hr after the last OVA challenge. Themean values (fivemice per group)
are shown with SD. **p < 0.01.
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Immunity
Eomesodermin Suppresses IL-5 in Memory Th2 Cellsthe development of memory Th2 cell-dependent allergic airway
inflammation demonstrating a role for Eomes in the regulation
of polarized function of CD4+ T cells.
EXPERIMENTAL PROCEDURES
Mice
The animals used in this studywere backcrossed toBALB/c orC57BL/6mice10
times. Anti-OVA-specificTCR-ab (DO11.10) transgenic (Tg)micewere provided
by D. Loh (Washington University School of Medicine, St. Louis) (Murphy et al.,
1990). Eomesfl/fl mice were kindly provided by S. Reiner (Pennsylvania Univer-
sity) (Intlekofer et al., 2008). Ly5.1 mice were purchased from Sankyo Labora-
tory. CD4-Cre mice were purchased from Taconic Farms (Germantown, NY).
All micewere used at 6–8weeks oldandweremaintainedunderSPFconditions.
BALB/c andBALB/c nu/numicewere purchased fromClea Inc. (Tokyo). Animal
care was conducted in accordance with the guidelines of Chiba University.
The Generation of Effector and Memory Th1 and Th2 Cells
Effector and memory Th1 and Th2 cells were generated as previously
described (Inami et al., 2004; Yamashita et al., 2006). The detailed protocols
are described in the Supplemental Experimental Procedures.
Flow Cytometry and Sorting
Memory Th2 cellswere stainedwith anti-CD62L-APCand anti-CXCR3-PE, and
four subpopulations (CD62LloCXCR3lo, CD62LloCXCR3hi, CD62LhiCXCR3lo,
and CD62LhiCXCR3hi) were purified by FACS. Memory Th2 cells were stimu-
latedwith immobilizedanti-TCRb for 6 hr, and IL-5+and IL-5cellswerepurified
with an IL-5 secretion assay kit (130-091-175, Miltenyi Biotec.) and FACS. The
other reagents used in flow cytometry are listed in the Supplemental Experi-
mental Procedures.
Quantitative Real-Time PCR and ELISA for the Measurement
of Cytokine Expression
Quantitative RT-PCR and ELISA were performed as described previously (Ya-
mashita et al., 2006).
Chromatin Immunoprecipitation Assay
ChIP assays were performed as described previously (Yamashita et al., 2002).
The antibodies and primer pairs used in the ChIP assays are listed in the
Supplemental Experimental Procedures.
siRNA Gene Targeting Analysis
siRNA was introduced into memory Th2 or MPCD4+ T cells by electroporation
with a mouse T cell Nucleofector Kit and Nucleofector I (Amaxa). Memory Th2
cells and MPCD4+ T cells were transfected with 675 pmole of control random
siRNAorsiRNA forEomesandTbx21 (AppliedBiosystems)andcultured for 24hr.
Immunoprecipitation, Immunoblotting, and Pull-Down Assay
The detailed protocol is described in the Supplemental Experimental
Procedures.(C) Two days after the last OVA challenge, the lungs were fixed and stained with pe
represent 100 mm.
(D) Quantitative RT-PCR analysis of Gob5 and Muc5ac from the lung tissue 2 da
(E) One day after the last OVA inhalation, changes in lung resistance (RL) were
deviations.
The experiments were performed twice with similar results (A, B, D, and E).
(F) The number of infiltrated leukocytes in the BAL fluid from whole or IL-5 mem
(G) ELISA analysis of IL-4, IL-5, IL-13, and IFN-g in the BAL fluid from each expe
(H and I) Eomes+/+ or Eomes/memory Th2 cells were generated by transferring
Th2 cells into TCRbd/ mice.
(H) Eomes+/+ or Eomes/ memory Th2 cells were stained with CD62L and CXC
(I) Eomes+/+ orEomes/memory Th2 cells were stimulated in vitro with immobiliz
with the percentage of cells in each area.
(J) The absolute cell numbers of leukocytes recovered in the BAL fluid of Eomes
(K) ELISA analysis of IL-4, IL-5, IL-13, and IFN-g in the BAL fluid of the experime
The experiments were performed twice with similar results (F–K).
IAssessment of Memory Th2 Cell Function In Vivo
OVA-specific memory Th2 cells were first generated in vivo (Nakayama and
Yamashita, 2009). AHR was assessed on day 4 as described previously
(Yamashita et al., 2008). The mRNA expression of Gob5 and Muc5ac in the
lung was assessed on day 5 (Yamashita et al., 2006). BAL fluid for the analysis
of cytokine production by ELISA was collected 12 hr after the last inhalation
and that for the assessment of inflammatory cell infiltration was collected on
day 5. Lung histology was assessed on day 5.
Statistical Analysis
Student’s t test was used for all comparisons, data represented asmean ± SD.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE33516.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at doi:10.
1016/j.immuni.2011.08.017.
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